Table 3.
Associations between vascular risk factors, laboratory findings and flow-mediated dilation (FMD).
| Flow-mediated dilation | ||||
|---|---|---|---|---|
| Spearman's correlation |
Multiple linear regression |
|||
| ρ | P | β coefficient | P | |
| Age | − 0.266 | 0.007 | − 0.229 | 0.016 |
| Male | − 0.309 | 0.002 | − 0.233 | 0.010 |
| Body mass index (kg/m2) | − 0.255 | 0.010 | – | – |
| Smoker | − 0.040 | 0.692 | – | – |
| Hypertension | − 0.305 | 0.002 | − 0.155 | 0.099 |
| Diabetes mellitus | − 0.277 | 0.005 | – | – |
| Dyslipidemia | − 0.093 | 0.351 | – | – |
| Atrial fibrillation | 0.056 | 0.576 | – | – |
| Renal dysfunction | − 0.208 | 0.036 | – | – |
| Systolic blood pressure (mm Hg) | − 0.079 | 0.429 | – | – |
| Diastolic blood pressure (mm Hg) | 0.082 | 0.415 | – | – |
| History of stroke | − 0.106 | 0.287 | – | – |
| History of coronary artery disease | − 0.095 | 0.344 | – | – |
| Laboratory findings | ||||
| White blood cells (103/μl) | − 0.012 | 0.902 | – | – |
| HbA1c (%) | − 0.187 | 0.060 | – | – |
| FBG (mg/dl) | − 0.161 | 0.106 | – | – |
| LDL cholesterol (mg/dl) | − 0.045 | 0.650 | – | – |
| HDL cholesterol (mg/dl) | 0.254 | 0.010 | – | – |
| TG (mg/dl) | − 0.280 | 0.004 | − 0.220 | 0.013 |
| eGFR (ml/min/1.73 m2) | 0.199 | 0.045 | – | – |
| hs-CRP, log (ng/ml) | − 0.224 | 0.024 | – | – |
| Telomere G-tail length (RLU/μg DNA) | 0.214 | 0.031 | 0.205 | 0.022 |
β coefficient means standardized partial regression coefficient.
FBG, fasting blood glucose; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; eGFR, estimated glomerular filtration rate; RLU, relative light unit; DNA, deoxyribonucleic acid.